CorMedix (CRMD) PT Raised to $17 at RBC Capital; 'Outpatient Strength Likely to Continue in 2H'
Tweet Send to a Friend
(Updated - June 20, 2025 10:13 AM EDT)
RBC Capital analyst Gregory Renza raised the price target on CorMedix ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
RBC Capital analyst Gregory Renza raised the price target on CorMedix ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
